These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2830824)

  • 1. The growth factor module of urokinase is the binding sequence for its receptor.
    Appella E; Blasi F
    Ann N Y Acad Sci; 1987; 511():192-5. PubMed ID: 2830824
    [No Abstract]   [Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.
    Blasi F; Vassalli JD; Danø K
    J Cell Biol; 1987 Apr; 104(4):801-4. PubMed ID: 3031083
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasminogen activation by receptor-bound urokinase.
    Ellis V; Danø K
    Semin Thromb Hemost; 1991 Jul; 17(3):194-200. PubMed ID: 1665584
    [No Abstract]   [Full Text] [Related]  

  • 4. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.
    Appella E; Robinson EA; Ullrich SJ; Stoppelli MP; Corti A; Cassani G; Blasi F
    J Biol Chem; 1987 Apr; 262(10):4437-40. PubMed ID: 3031025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic urokinase binding sites on human foreskin fibroblasts.
    Bajpai A; Baker JB
    Biochem Biophys Res Commun; 1985 Dec; 133(2):475-82. PubMed ID: 3002345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Duffy MJ; Duggan C
    J Natl Cancer Inst; 1997 Nov; 89(21):1628-30. PubMed ID: 9362165
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hasui Y; Osada Y
    J Natl Cancer Inst; 1997 Nov; 89(21):1630-1. PubMed ID: 9362166
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to comment on 'Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system' (A. A-R. Higazi).
    Behrendt N; Danø K
    FEBS Lett; 1997 Feb; 402(2-3):293-4. PubMed ID: 9037213
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary on: 'Effect of purified soluble urokinase receptor on the plasminogen prourokinase activation system' by N. Behrendt and K. Dano, FEBS Letters, 393 (1996) 31-36.
    Higazi AA
    FEBS Lett; 1997 Feb; 402(2-3):291-2. PubMed ID: 9037212
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular receptor for urokinase-type plasminogen activator: protein structure.
    Behrendt N; Ploug M; Rønne E; Høyer-Hansen G; Danø K
    Methods Enzymol; 1993; 223():207-22. PubMed ID: 8271954
    [No Abstract]   [Full Text] [Related]  

  • 14. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.
    Pyke C; Kristensen P; Ralfkiaer E; Grøndahl-Hansen J; Eriksen J; Blasi F; Danø K
    Am J Pathol; 1991 May; 138(5):1059-67. PubMed ID: 1850957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
    Braungart E; Magdolen V; Degitz K
    J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase receptor up-regulation in head and neck squamous cell carcinoma.
    Schmidt M; Schler G; Gruensfelder P; Müller J; Hoppe F
    Head Neck; 2000 Aug; 22(5):498-504. PubMed ID: 10897110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase.
    Corti A; Sarubbi E; Soffientini A; Nolli ML; Zanni A; Galimberti M; Parenti F; Cassani G
    Thromb Haemost; 1989 Nov; 62(3):934-9. PubMed ID: 2480654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
    Stoppelli MP; Corti A; Soffientini A; Cassani G; Blasi F; Assoian RK
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4939-43. PubMed ID: 2991901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.